3.440USD-3.37%Mkt Cap: 246.73M $P/E: 12.291d ago
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.97BUSD
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.16BUSD
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.79MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap246.73M $
Enterprise Value110.38M $
Revenue (TTM)93.78M $
Gross Profit64.87M $
Net Income (TTM)23.28M $
Revenue/Share1.310 USD
Last Price3.440 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.29
P/E (Forward)3.39
PEG3.37
EV/EBITDA5.20
EV/Revenue1.18
P/S2.72
P/B1.68
EPS (TTM)0.28
EPS (Forward)1.05
52W Range
3.4100% of range9.620
52W High9.620 USD
52W Low3.410 USD
Profitability
Gross Margin68.59%
Oper. Margin-85.24%
EBITDA Margin22.62%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.47M $
CapEx (TTM)355.01K $
FCF Margin63.39%
FCF Yield24.09%
Net Debt-144.96M $
Net Debt/EBITDA-6.83
Balance Sheet
Debt/Equity0.00
Current Ratio3.25
Quick Ratio2.30
Book Value/Sh2.114 USD
Cash/Share2.029 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateApr 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.72M
Float41.01M
Insiders42.80%
Institutions49.87%
Short Interest
Short Ratio6.2d
Short % Float7.47%
Short % Out.4.83%
Shares Short3.46M
Short (prev mo.)3.57M
Technical
SMA 504.233 (-18.7%)
SMA 2005.883 (-41.5%)
Beta0.89
S&P 52W Chg20.25%
Avg Vol (30d)548.48K
Avg Vol (10d)578.53K
Technical Indicators
RSI (14)32.2
MACD-0.2270
MACD Signal-0.2149
MACD Hist.-0.0121
BB Upper4.470 USD
BB Middle3.819 USD
BB Lower3.168 USD
BB Width34.08%
ATR (14)0.1681 USD
Vol Ratio (20d)0.50x